Turning Point Brands Canada Becomes Exclusive Distributor for VPRB's HoneyStick in Canada

Business by 2FIRSTS.ai
Jan.09.2024
Turning Point Brands Canada Becomes Exclusive Distributor for VPRB's HoneyStick in Canada
VPR Brands announces Turning Point Brands Canada as the exclusive distributor of its HoneyStick products in Canada.

VPR Brands (OTC: VPRB) recently announced that Turning Point Brands Canada (TPB) will serve as the exclusive distributor for its HoneyStick products in Canada.

 

VPR Brands (VPRB) is an e-cigarette manufacturer dedicated to introducing innovative products.

 

TPB is a Canadian marketing and distribution company in the field of tobacco, e-cigarettes, and alternative products.

 

HoneyStick is set to join TPB Canada's portfolio of leading global brand management, alongside iconic brands such as Zig-Zag, Clipper, Choice Leaf, HMP, Rebound, and Evolve, to enter the Canadian market.

 

In the future, TPB Canada will streamline the retail process by centralizing ordering, logistics, and warehousing in one location. This will ensure a steady supply of HoneyStick products and reduce delivery times, enabling faster product delivery across Canada.

 

Currently, HoneyStick has launched on the Canadian e-commerce platform tpbmarketplace. However, it is either marked as "sold out" or yet to be available on several other Canadian e-commerce platforms.

 

Mikail Fancy, Chief Operating Officer of Turning Point Brands Canada, expressed enthusiasm over the partnership with VPR Brands to bring HoneyStick to a wider audience in Canada. Fancy highlighted the combination of their expertise in marketing, sales, distribution, and logistics, along with the quality and innovation of HoneyStick products, as a perfect match. He emphasized their commitment to providing excellent service and support for retailers and consumers.

 

Daniel Hoff, Chief Operating Officer of VPR Brands, has stated that the collaboration with Turning Point Brands Canada is a significant milestone for HoneyStick in Canada. Their strong distribution network and successful experience in marketing, sales, and customer service make them an ideal partner to enhance our brand's presence and accessibility nationwide.

 

VPR is currently involved in a significant case regarding a legal dispute with IMiracle (Heaven Gifts). The main point of contention revolves around the usage rights of the term "Elf" on e-cigarette products.

 

VPR filed a lawsuit in October 2022 against the distributor Shenzhen Weibo Li Technology Co., Ltd and the manufacturer iMiracle (HK) Limited, alleging infringement of VPR's trademark rights on ELF during the sales of Elfbar. Elfbar is the most popular disposable e-cigarette brand among young users.

 

In response, Judge Cannon in the United States issued a temporary injunction on Chinese companies in February 2023, prohibiting them from selling any e-cigarette products bearing the name ELFBAR. Judge Cannon stated that there is currently "no dispute" that these companies intentionally infringed upon VPR's trademark rights.

 

Shenzhen V-Perfect and iMiracle have submitted their first document claiming that they can prove V-Perfect is not the original user of the ELF trademark. According to the documents submitted by these two companies on April 24th, they have discovered the true owner of the ELF trademark, another Chinese company called GD Sigelei Electronic Tech. This company first used the "ELF" to sell e-cigarette products in April 2016, almost a year and a half earlier than V-Perfect's first batch of ELF products.

 

In March of this year, two Chinese companies signed a trademark transfer agreement, claiming to have transferred the rights to the Elf trademark to iMiracle. Based on this, they have requested Judge Cannon to revoke the temporary injunction.

 

Another important document claims that VPR has utilized a court order prohibiting them from manufacturing ELFBAR in order to seek market share. According to the document from May, VPR has launched a "blatantly imitated" ELFBAR disposable e-cigarette, clearly copying iMiracle's product. Both of these Chinese companies argue that these inferior counterfeit products will confuse consumers, ultimately leading to ELFBAR losing market share and reputation.

 

Although both parties have informed the mediators that Judge Cannon's decision on these two motions will "guide their positions for settlement," the case remains at a standstill, waiting for the Chinese companies to appeal to the Federal Circuit in an attempt to overturn the injunction. These two Chinese companies are dissatisfied with the temporary ban and stated in their submission to the Federal Circuit that the injunction is erroneous and has resulted in them losing millions of dollars.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

China Tobacco Plans CNY 60 Billion Investment in ICBC, Agricultural Bank as Strategic Ties Extend Beyond Equity
China Tobacco Plans CNY 60 Billion Investment in ICBC, Agricultural Bank as Strategic Ties Extend Beyond Equity
China National Tobacco Corporation and several subsidiaries plan to invest a combined CNY 60 billion ($8.7 billion) in share placements by Industrial and Commercial Bank of China and Agricultural Bank of China as strategic investors. The agreements extend beyond equity investment to corporate governance, banking services and supply-chain finance. The filings also disclose 2025 data on China Tobacco’s tax and profit contributions and industry scale.
Sep.07
FDA Unifies Tobacco Registration and Product Listing Form Across Product Categories
FDA Unifies Tobacco Registration and Product Listing Form Across Product Categories
The U.S. FDA has consolidated two tobacco establishment registration and product listing forms into a redesigned Form FDA 3741 covering all regulated product categories, including e-cigarettes, heated tobacco products and nicotine pouches. The current requirements remain limited to domestic establishments. Separately, the FDA has proposed extending registration and product listing requirements to foreign manufacturers, signaling greater regulatory attention to manufacturing entities and product-level information across the tobacco and nicotine supply chain.
FDA
Sep.30
Earnings Analysis | CTIHK H1 2026 Revenue Falls 26.9% as Core Businesses Diverge and New Growth Drivers Remain to Be Proven
Earnings Analysis | CTIHK H1 2026 Revenue Falls 26.9% as Core Businesses Diverge and New Growth Drivers Remain to Be Proven
China Tobacco International (HK) reported a 26.9% revenue decline in H1 2026, while gross profit fell only 9.5%, revealing sharp divergence across its businesses. Tobacco leaf imports contracted, while leaf exports and Brazil operations expanded strongly. Cigarette exports faced China duty-free market transition, and new tobacco products remained small. Meanwhile, CTIHK continues to strengthen its role as an investment and financing platform, though major external deals have yet to emerge. 2Firsts examines what these shifts mean for its next growth drivers.
Capital Markets
Aug.24
Charlie’s Bets on Age-Gating and 678 PMTA Assets as U.S. Vape Enforcement Landscape Shifts
Charlie’s Bets on Age-Gating and 678 PMTA Assets as U.S. Vape Enforcement Landscape Shifts
Charlie’s Holdings said in its latest shareholder letter that it is moving to commercialize PACHA products and monetize its PMTA assets as the FDA changes enforcement priorities for unauthorized ENDS products. Thirty PACHA SKUs were previously tentatively identified for a proposed public list of products that the FDA generally does not intend to prioritize for enforcement. Charlie’s is also preparing test-market sales of age-gated flavored disposables and says it currently holds 678 PMTA-related product assets while seeking additional strategic transactions and partnerships.
Sep.11
Special Report | From New York to Washington: How FDA’s Tobacco Center Is Reworking Product Review
Special Report | From New York to Washington: How FDA’s Tobacco Center Is Reworking Product Review
FDA’s Center for Tobacco Products is reshaping how it approaches tobacco product review. Based on 2Firsts’ on-site reporting in New York and Washington, this report traces CTP’s emerging direction: stronger links between PMTA and tobacco harm reduction, more category-specific review, greater emphasis on decision-relevant science, more predictable timelines and expanded use of sPMTA for product modifications. CTP also acknowledged major constraints, including just nine PMTA review teams, persistent backlogs and limits on hiring capacity.
Regulations
Oct.08
Malaysia Liquid Nicotine Returns to Poisons List, Leaving Vape Retail and RM354 Million Tax Collection in Legal Uncertainty
Malaysia Liquid Nicotine Returns to Poisons List, Leaving Vape Retail and RM354 Million Tax Collection in Legal Uncertainty
Malaysia’s withdrawal of its appeal in a landmark liquid-nicotine case has left a High Court ruling that struck down the 2023 nicotine exemption in force, bringing liquid and gel nicotine used in vaping products back under the Poisons Act 1952. At the same time, the Control of Smoking Products for Public Health Act 2024 continues to provide a regulatory framework for vaping products, creating uncertainty over retail sales, taxation and existing inventory. MPs are calling for nicotine vape sales and excise collection to stop, including refunds of more than RM354 million collected since 2023, while industry and consumer groups are asking the government to clarify the current legal position.
Sep.04